Australia's Genetic Signatures jumps on US FDA nod for diagnosis kit

Genetic Signatures

06/06/2024 04:36

** Shares of molecular diagnostics firm Genetic Signatures
 GSS.AX  rise as much as 16.4% to A$0.850, their highest since
mid-Feb 2023
    ** Stock posts its biggest intraday pct gain since March 4
    ** Co said on Wednesday the U.S. Food and Drug
Administration cleared its 'EasyScreen' gastrointestinal
parasite detection kit in the U.S.
    ** Over 1 mln shares change hands, compared with the 30-day
average volume of around 120,000
    ** Stock up 67.8% YTD, based on last close

 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))